Chinese Biopharma Firm Asieris Completes RMB700M Round

Asieris Pharmaceuticals is a China-based biotech company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumors and related diseases.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in

LEAVE A REPLY